World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: REBEC
Last refreshed on: 29 May 2023
Main ID:  RBR-8h32gy
Date of registration: 17/08/2015
Prospective Registration: No
Primary sponsor: Universidade Federal de Sergipe
Public title: Effect of intensity of electric current and evidence of blinding method
Scientific title: Effect of intensity of interferential current and validation of the placebo method
Date of first enrolment: 15/08/2012
Target sample size:
Recruitment status: Data analysis completed
URL:  http://ensaiosclinicos.gov.br/rg/RBR-8h32gy
Study type:  Intervention
Study design:  Randomized clinical trial, parallel, double blind, five arm.  
Phase:  N/A
Countries of recruitment
Brazil
Contacts
Name: Josimari Melo   de Santana
Address:  Departamento de Fisioterapia, Hospital Universitário /UFS, Rua Cláudio Batista, s/n 49060-100 Aracaju Brazil
Telephone: +55(79)21051804
Email: desantana@pq.cnpq.br
Affiliation:  Universidade Federal de Sergipe
Name: Fernanda Mendonça   Araújo
Address:  Avenida Augusto Franco, n. 3553, bloco G, apto. 503 49047-040 Aracaju Brazil
Telephone: +55(79)32312841
Email: nanda.maraujo@hotmail.com
Affiliation:  Universidade Federal de Sergipe
Key inclusion & exclusion criteria
Inclusion criteria: Healthy subjects; 18 to 60 years of age.
Exclusion criteria: Participants with peripheral nerve injury in the upper limbs; presence of pain in the upper limbs; pregnancy; chronic diseases; use of cardiac pacemaker; epilepsy; allergy to the material of the electrodes; current use of analgesic medication or in the last seven days; altered skin conditions or loss of sensation in the established areas of electrode placement.

Age minimum: 18Y
Age maximum: 60Y
Gender: -
Health Condition(s) or Problem(s) studied
R52.9
Unspecified pain
Intervention(s)
Other
D26.660
The subjects were randomly divided into five groups, described as follows:
Adjusted motor group: 25 participants of both sexes were recruited, the interferential current (IFC) was applied for 30 minutes and a frequency of 100Hz was used, the intensity was gradually increased until a strong contraction but comfortable reported by the subject; at intervals of 5 minutes, the intensity was increased again until a strong sensation.
Fixed motor group: 25 participants of both sexes were recruited, the IFC was applied for 30 minutes at a frequency of 100Hz, the intensity was gradually increased until a strong contraction, but comfortable; this intensity was maintained at this level throughout the procedure.
Sensory group: 25 participants of both sexes were recruited, the IFC was applied for 30 minutes at a frequency of 100Hz, the intensity was increased until a motor contraction was produced, and then the pulse amplitude was decreased to 10% below motor contraction.
Inactive placebo group: 25 participants of both sexes were recruited, the subjects were connected to an IFC device that was turned on to appear that the device was functioning, but no stimulation was delivered; the subjects were connected to the device for 30 minutes.
New placebo group: 25 participants of both sexes were recruited, an external device, manufactured exclusively for this study, was connected to the IFC device in order to modify the release of electrical current, enabling the current to be released only during the first 40 seconds of stimulation (at frenquency of 100Hz), and then cease the passage of current; the subjects were connected to the device for 30 minutes.
In all groups, the electrodes were placed on the subject's forearm.
E02.342
Primary Outcome(s)
At the end of the study, it was observed a percentage of 60% of subjects, included in the new placebo group, who believed they received active treatment.
Over 50% of subjects, included in the new placebo group, respond receiving an active treatment, when questioned by the investigator immediately after the intervention.
Secondary Outcome(s)
At the end of study, none of the placebo groups significantly altered the pressure pain threshold, cutaneous sensitive threshold and pain intensity after treatment, presenting a difference greater than 5% of pretreatment value. Only in the adjusted motor group there was significant change less than 5% in all variables.
Let there be no significant changes in the pressure pain threshold, measured by digital algometry, in the cutaneous sensitive threshold, measured by esthesiometry, and in the pain intensity, measured by 11-point numerical rating scale, after intervention in the placebo groups, from the observation of a greater variation than 5% in pre and post treatment.
Secondary ID(s)
Source(s) of Monetary Support
Universidade Federal de Sergipe
Secondary Sponsor(s)
Universidade Federal de Sergipe
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history